Hester Biosciences Schedules Board Meeting to Consider Q2 Results
Hester Biosciences Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Hester Biosciences Schedules Board Meeting to Consider Q2 Results Hester Biosciences Limited has scheduled a meeting of its Board of Directors on 5th Nov'26. The board will meet, inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and six-month period ended 30th Sep'26, in compliance with Regulation 29 of SEBI LODR Regulations.
Original exchange filing (PDF)
More announcements from Hester Biosciences Ltd
- 20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results 路 07 Nov 2026
- Audio recording of the Earnings Conference Call for Q2 FY 27 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange about Board have approved an Unsecured loan of an aggregate amount of USD 1 million to Hester Biosciences Africa Limited( Hester Africa ), foreign wholly-owned subsidiary in Tanzania, in one or more tranches. 路 05 Nov 2026
- Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited, Foreign wholly-owned subsidiary of the Company. 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "20261105 Q2 & H1 FY27 Press Release". 路 05 Nov 2026
- 20261105 Q2 & H1 FY27 Press Release 路 05 Nov 2026
- Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on 5 November 2026 and Financial Results for the Q2 & H1 FY 2026-27 路 05 Nov 2026
